vs

Side-by-side financial comparison of HEALTHSTREAM INC (HSTM) and MIMEDX GROUP, INC. (MDXG). Click either name above to swap in a different company.

MIMEDX GROUP, INC. is the larger business by last-quarter revenue ($118.1M vs $79.7M, roughly 1.5× HEALTHSTREAM INC). On growth, MIMEDX GROUP, INC. posted the faster year-over-year revenue change (27.1% vs 7.4%). Over the past eight quarters, MIMEDX GROUP, INC.'s revenue compounded faster (18.1% CAGR vs 4.7%).

HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

HSTM vs MDXG — Head-to-Head

Bigger by revenue
MDXG
MDXG
1.5× larger
MDXG
$118.1M
$79.7M
HSTM
Growing faster (revenue YoY)
MDXG
MDXG
+19.7% gap
MDXG
27.1%
7.4%
HSTM
Faster 2-yr revenue CAGR
MDXG
MDXG
Annualised
MDXG
18.1%
4.7%
HSTM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HSTM
HSTM
MDXG
MDXG
Revenue
$79.7M
$118.1M
Net Profit
$15.2M
Gross Margin
83.9%
Operating Margin
3.0%
17.8%
Net Margin
12.9%
Revenue YoY
7.4%
27.1%
Net Profit YoY
104.2%
EPS (diluted)
$0.09
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HSTM
HSTM
MDXG
MDXG
Q4 25
$79.7M
$118.1M
Q3 25
$76.5M
$113.7M
Q2 25
$74.4M
$98.6M
Q1 25
$73.5M
$88.2M
Q4 24
$74.2M
$92.9M
Q3 24
$73.1M
$84.1M
Q2 24
$71.6M
$87.2M
Q1 24
$72.8M
$84.7M
Net Profit
HSTM
HSTM
MDXG
MDXG
Q4 25
$15.2M
Q3 25
$6.1M
$16.7M
Q2 25
$5.4M
$9.6M
Q1 25
$4.3M
$7.0M
Q4 24
$7.4M
Q3 24
$5.7M
$8.1M
Q2 24
$4.2M
$17.6M
Q1 24
$5.2M
$9.3M
Gross Margin
HSTM
HSTM
MDXG
MDXG
Q4 25
83.9%
Q3 25
83.5%
Q2 25
81.1%
Q1 25
81.2%
Q4 24
81.8%
Q3 24
81.8%
Q2 24
83.0%
Q1 24
84.7%
Operating Margin
HSTM
HSTM
MDXG
MDXG
Q4 25
3.0%
17.8%
Q3 25
9.9%
19.5%
Q2 25
7.9%
12.5%
Q1 25
6.0%
9.4%
Q4 24
6.3%
11.9%
Q3 24
8.9%
13.3%
Q2 24
6.2%
26.9%
Q1 24
7.8%
15.6%
Net Margin
HSTM
HSTM
MDXG
MDXG
Q4 25
12.9%
Q3 25
8.0%
14.7%
Q2 25
7.2%
9.8%
Q1 25
5.9%
8.0%
Q4 24
8.0%
Q3 24
7.8%
9.6%
Q2 24
5.8%
20.2%
Q1 24
7.2%
10.9%
EPS (diluted)
HSTM
HSTM
MDXG
MDXG
Q4 25
$0.09
$0.10
Q3 25
$0.20
$0.11
Q2 25
$0.18
$0.06
Q1 25
$0.14
$0.05
Q4 24
$0.16
$0.05
Q3 24
$0.19
$0.05
Q2 24
$0.14
$0.12
Q1 24
$0.17
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HSTM
HSTM
MDXG
MDXG
Cash + ST InvestmentsLiquidity on hand
$36.2M
$166.1M
Total DebtLower is stronger
$18.0M
Stockholders' EquityBook value
$354.0M
$256.5M
Total Assets
$520.4M
$342.7M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HSTM
HSTM
MDXG
MDXG
Q4 25
$36.2M
$166.1M
Q3 25
$53.5M
$142.1M
Q2 25
$52.1M
$118.9M
Q1 25
$77.3M
$106.4M
Q4 24
$59.5M
$104.4M
Q3 24
$57.5M
$88.8M
Q2 24
$46.1M
$69.0M
Q1 24
$52.4M
$48.5M
Total Debt
HSTM
HSTM
MDXG
MDXG
Q4 25
$18.0M
Q3 25
Q2 25
Q1 25
Q4 24
$19.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
HSTM
HSTM
MDXG
MDXG
Q4 25
$354.0M
$256.5M
Q3 25
$349.2M
$238.9M
Q2 25
$350.6M
$216.6M
Q1 25
$362.8M
$202.8M
Q4 24
$359.4M
$193.1M
Q3 24
$355.5M
$181.0M
Q2 24
$349.2M
$168.0M
Q1 24
$344.9M
$155.7M
Total Assets
HSTM
HSTM
MDXG
MDXG
Q4 25
$520.4M
$342.7M
Q3 25
$499.9M
$319.0M
Q2 25
$500.1M
$291.1M
Q1 25
$524.0M
$270.4M
Q4 24
$510.8M
$263.9M
Q3 24
$502.8M
$243.9M
Q2 24
$499.6M
$230.2M
Q1 24
$511.6M
$221.7M
Debt / Equity
HSTM
HSTM
MDXG
MDXG
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HSTM
HSTM
MDXG
MDXG
Operating Cash FlowLast quarter
$13.2M
$25.0M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
16.3%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters
$59.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HSTM
HSTM
MDXG
MDXG
Q4 25
$13.2M
$25.0M
Q3 25
$18.0M
$29.3M
Q2 25
$5.0M
$14.4M
Q1 25
$27.1M
$5.3M
Q4 24
$11.2M
$18.8M
Q3 24
$19.1M
$19.6M
Q2 24
$6.5M
$21.8M
Q1 24
$20.9M
$6.0M
Free Cash Flow
HSTM
HSTM
MDXG
MDXG
Q4 25
$13.0M
Q3 25
$17.9M
Q2 25
$2.7M
Q1 25
$26.0M
Q4 24
$11.0M
Q3 24
$18.8M
Q2 24
$6.3M
Q1 24
$20.2M
FCF Margin
HSTM
HSTM
MDXG
MDXG
Q4 25
16.3%
Q3 25
23.4%
Q2 25
3.6%
Q1 25
35.4%
Q4 24
14.8%
Q3 24
25.8%
Q2 24
8.8%
Q1 24
27.8%
Capex Intensity
HSTM
HSTM
MDXG
MDXG
Q4 25
0.3%
Q3 25
0.1%
Q2 25
3.1%
Q1 25
1.4%
Q4 24
0.3%
Q3 24
0.4%
Q2 24
0.2%
Q1 24
1.0%
Cash Conversion
HSTM
HSTM
MDXG
MDXG
Q4 25
1.64×
Q3 25
2.96×
1.75×
Q2 25
0.93×
1.50×
Q1 25
6.25×
0.75×
Q4 24
2.53×
Q3 24
3.34×
2.42×
Q2 24
1.55×
1.24×
Q1 24
4.01×
0.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HSTM
HSTM

Subscription Services$77.0M97%
Professional Services$2.7M3%

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

Related Comparisons